Tempus AI (TEM) announced the presentation of six posters, including one oral presentation, at the 2025 annual meeting of the Professional Society for Health Economics and Outcomes Research – ISPOR – taking place May 13-16 in Montreal, Canada. Tempus researchers are showcasing scientific and clinical studies highlighting the impact of AI and real-world data on health economics and outcomes research. “The research we’re presenting at ISPOR 2025 underscores the powerful potential of integrating clinical, molecular, and claims data to unlock actionable insights that drive more personalized and effective cancer care,” said Emilie Scherrer, Senior Director and Head of Outcomes Research, at Tempus.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- Unusually active option classes on open May 9th
- Tempus AI Reports Strong Growth and Strategic Partnerships in Earnings Call
- Tempus AI, Inc.: Mixed Signals Prompt Hold Rating Amid Revenue Growth and Cash Flow Concerns
- Tempus AI price target raised to $65 from $60 at BTIG
- Tempus AI, Inc.: Strong Q1 Performance and Strategic Growth Initiatives Justify Buy Rating